Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
High Tech Pharmaceuticals Co., Ltd. (106190)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
11,520.
00
-360
-3.0303%
₩
168.1B
Market Cap
-
P/E Ratio
266.67%
Div Yield
9,737
Volume
-
Eps
₩
11,880
Previous Close
Watching
Watch
Add Transaction
Day Range
11,460
11,950
Year Range
9,540
25,000
Want to track
106190
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
High Tech Pharmaceuticals Co., Ltd. (106190) Statistics
Valuation metrics
Market Cap
168.1B
Enterprise value
149.35B
Trailing P/E (ttm)
11.96
Forward P/E
-
PEG ratio
0.2
Price/Sales (ttm)
2.4
Price/Book (mrq)
1.29
Enterprise Value/Revenue
2.13
Enterprise Value/EBITDA
8.17
Overview
Shares outstanding
10.63M
Float
5.81M
Shares short
-
% Held by insiders
0.45%
% Held by institutions
0%
Average volume (10 days)
63.64K
Average volume (90 days)
68.17K
Price summary
52-Week low
9,540
52-Week high
25,000
Beta
0.06
50-Day moving average
18,597.6
200-Day moving average
14,196.05
Dividends and splits
Forward annual dividend rate
266.67
Forward annual dividend yield
0.0169%
Trailing annual dividend rate
66.67
Trailing annual dividend yield
0.0042%
5-Year annual dividend yield
0.63%
Payout ratio
0.18
Dividend Date
3 Jan 2025
Ex-Dividend Date
27 Dec 2024
Last split factor
1:1
Last split Date
27 Dec 2023
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.16%
Operating margin
0.23%
Operational effectiveness
Return on assets
0.06%
Return on equity
0.09%
Income Statement
Revenue (ttm)
70.18B
Revenue per share (ttm)
6,600.75
Quarterly revenue growth (yoy)
-0.28%
Gross profit (ttm)
16.94B
EBITDA
17.76B
Net income to common (ttm)
11.48B
Diluted EPS (ttm)
1,289
Quarterly earnings growth (yoy)
-0.14%
Balance Sheet
Total cash (mrq)
14.43B
Total cash per share (mrq)
1,357.12
Total debt (mrq)
33.61M
Total Debt/Equity (mrq)
0.03
Current ratio (mrq)
5.67%
Book value per share (mrq)
11,943.64
Cash Flow
Cash flow statement
17.03B
Levered free cash flow (LFCF)
13.25B